Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$1.54M+115%-$9.75M+3.5%-$10.81M-351%-$8.29M-91.3%-$10.38M+21.4%
$135K-21.5%$126K-34.7%$163K-10.4%$165K-14.9%$172K-1.7%
$2.47M+52.6%$2.2M+29.5%$3.42M+147%$1.89M+48.4%$1.62M+49.2%
-$6.48M-44.0%-$2.48M+56.5%-$3.71M+65.8%-$7.32M+45.5%-$4.5M+58.6%
$141K-81.3%$41K-18.0%$216K+27.8%$754K+1,042%
-$141K+80.3%-$41K+18.0%-$176K-4.1%-$714K-982%
$42.39M+338%$277K-90.7%$82K-98.6%$20.72M-20.3%$9.69M+210%
$35.76M+699%$13.49M+7.8%$4.48M+157%
-$6.62M-26.0%-$2.53M+56.1%-$3.93M+64.4%-$7.23M+46.4%-$5.25M+52.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does TriSalus Life Sciences, Inc. generate?
TriSalus Life Sciences, Inc. (TLSI) generated -$20.0M in operating cash flow over the trailing twelve months.
What is TriSalus Life Sciences, Inc.'s free cash flow?
After $1.2M of capital expenditures, TriSalus Life Sciences, Inc.'s free cash flow was -$20.3M over the trailing twelve months, up 42.8% year over year.
Where does TriSalus Life Sciences, Inc.'s cash flow data come from?
Every line is extracted from TriSalus Life Sciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.